As set out in the Cancer Reform Strategy, the National Cancer Director will repeat his evaluation of NICE approved cancer drug usage during 2008. It is expected that the evaluation report will be published before the end of the year.
As set out in the Cancer Reform Strategy, the National Cancer Director will repeat his evaluation of NICE approved cancer drug usage during 2008. It is expected that the evaluation report will be published before the end of the year.